Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in MiceDavid M. Alvarado, Matthew A. Ciorba, Sarada C. Prasad et al.|Inflammatory Bowel Diseases|2021Cited by 7
Tu1110: EXPRESSION OF EPITHELIAL PROTEASES PREDICTS SARS-COV-2 ENTRY IN HUMAN ENTEROIDSDavid M. Alvarado, Matthew A. Ciorba, Juhee Son et al.|Gastroenterology|2022Cited by 0